Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

Saved in:
Bibliographic Details
Title: Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.
Authors: Gögenur I; Center for Surgical Science, Zealand University Hospital, Køge, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Justesen TF; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Tarpgaard LS; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Bulut M; Center for Surgical Science, Zealand University Hospital, Køge, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Surgery, Zealand University Hospital, Køge, Denmark., Hansen TF; Department of Oncology, Vejle Hospital, Vejle, Denmark., Jensen LH; Department of Oncology, Vejle Hospital, Vejle, Denmark., Rahr HB; Department of Surgery, Colorectal Cancer Center South at Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Gögenur M; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Kirkegaard T; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Balsevicius L; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Chieng M; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Raskov H; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Sørensen MKS; Center for Surgical Science, Zealand University Hospital, Køge, Denmark., Petersen PC; Department of Oncology, Zealand University Hospital, Roskilde, Denmark., Eriksen JR; Department of Surgery, Zealand University Hospital, Køge, Denmark., Salomon S; Department of Surgery, Odense University Hospital, Odense, Denmark., Fiehn AK; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Pathology, Zealand University Hospital, Roskilde, Denmark., Mikkelsen MD; Department of Pathology, Zealand University Hospital, Roskilde, Denmark., Brandsborg S; Department of Surgery, Horsens Regional Hospital, Horsens, Denmark., Gotschalck KA; Department of Surgery, Horsens Regional Hospital, Horsens, Denmark., Emmertsen KJ; Department of Surgery, Randers Regional Hospital, Randers, Denmark., Ramlov A; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Born PW; Department of Surgery, Hvidovre Hospital, Hvidovre, Denmark., Thorlacius-Ussing O; Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Denmark., Lauritzen MB; Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark., Olesen RK; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Poulsen LØ; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Lykke J; Department of Surgery, Herlev and Gentofte University Hospital, Herlev, Denmark., Schou J; Department of Oncology, Herlev and Gentofte University Hospital, Herlev, Denmark., Buskov L; Department of Radiology, Bispebjerg Hospital, Bispebjerg, Denmark., Krarup PM; Department of Surgical Gastroenterology, Bispebjerg Hospital, Bispebjerg, Denmark., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Pallisgaard N; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.; Department of Science and Environment, Roskilde University, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun 20; Vol. 44 (18), pp. 1687-1696. Date of Electronic Publication: 2026 May 05.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-25-02274